|
Clinicopathological characteristics
|
TYK2 protein expression level
|
|---|
|
Low (n = 45)
|
High (n = 46)
|
P
|
|---|
|
Gender
|
|
Male
|
29 (64.4%)
|
39 (84.8%)
|
0.113
|
|
Female
|
16 (35.6%)
|
7 (15.2%)
| |
|
Age
|
|
≤ 60
|
14 (31.1%)
|
17 (37.0%)
|
0.761
|
|
> 60
|
31 (68.9%)
|
29 (63.0%)
| |
|
Tumor size
|
|
≤ 5 cm
|
31 (68.9%)
|
25 (54.3%)
|
0.528
|
|
> 5 cm
|
14 (31.1%)
|
21 (45.7%)
| |
|
Histological grade
|
|
Well/moderately
|
30 (66.7%)
|
37 (80.4%)
|
0.355
|
|
Poorly
|
15 (33.3%)
|
9 (19.6%)
| |
|
T classification
|
|
T1
|
4 (8.9%)
|
2 (4.3%)
|
0.543
|
|
T2
|
7 (15.6%)
|
5 (10.9%)
| |
|
T3
|
32 (71.1%)
|
38 (82.6%)
| |
|
T4
|
2 (4.4%)
|
1 (2.2%)
| |
|
N classification
|
|
N0
|
22 (48.9%)
|
19 (41.3%)
|
0.448
|
|
N1
|
16 (35.6%)
|
14 (30.4%)
| |
|
N2
|
6 (13.3%)
|
10 (21.8%)
| |
|
N3
|
1 (2.2%)
|
3 (6.5%)
| |
|
Clinical stage
|
|
1
|
5 (11.1%)
|
2 (4.4%)
|
0.033
|
|
2
|
20 (44.5%)
|
19 (41.3%)
| |
|
3
|
18 (40.0%)
|
21 (45.6%)
| |
|
4
|
2 (4.4%)
|
4 (8.7%)
| |
